Skip to main content
Top
Published in: Netherlands Heart Journal 1/2017

Open Access 01-01-2017 | Original Article

Effects of radial versus femoral artery access in patients with acute myocardial infarction: A large centre prospective registry

Authors: S. Kilic, R. S. Hermanides, J. P. Ottervanger, E. Kolkman, J. H. E. Dambrink, V. Roolvink, A. T. M. Gosselink, E. Kedhi, A. W. J. van ’t Hof, Zwolle Myocardial Infarction Study Group

Published in: Netherlands Heart Journal | Issue 1/2017

Login to get access

Abstract

Aim

This study sought to assess whether radial artery access improves clinical outcomes in patients presenting with acute myocardial infarction compared with femoral artery access.

Methods

This is a single-centre, prospective observational registry of all STEMI and NSTEMI patients who underwent coronary angiography and/or primary PCI in the period January 2010 to December 2013. Primary endpoint was 30-day all-cause mortality. Choice of access was left to the discretion of the cardiologist. Differences in the risk of death at 30 days between patients undergoing transradial intervention versus transfemoral intervention was assessed on an intention-to-treat comparison.

Results

Retrospective analysis of prospectively collected data was performed in 3580 patients with an acute coronary syndrome who underwent coronary angiography, of which 1310 had radial artery access. PCI was performed in 77 % of the patients. Before propensity score matching, patients who underwent transradial intervention and those intended to undergo transfemoral approach differed significantly in intra-aortic balloon pump use (1.7 % vs. 6.7 %, p < 0.001), and Killip class (Killip 1: 10.8 % vs. 17.3 %, p < 0.001). 30-day mortality rates were 1.7 % in the transradial group and 4.6 % in the transfemoral group (p < 0.001). After matching on the propensity score, the hazard ratio for 30-day mortality in the transradial group was 0.56 (95 % CI: 0.29–1.07, p = 0.08).

Conclusion

This registry-based study showed that radial access is associated with improved outcome in patients with an acute coronary syndrome. However, this difference was no longer significant after multivariate and propensity score adjustment for differences in baseline characteristics.
Literature
1.
go back to reference ten Berg JM, van ’t Hof AWJ, Dill T, et al. On-TIME 2 study group. Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome. J Am Coll Cardiol. 2010;55:2446–55.CrossRefPubMed ten Berg JM, van ’t Hof AWJ, Dill T, et al. On-TIME 2 study group. Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome. J Am Coll Cardiol. 2010;55:2446–55.CrossRefPubMed
2.
go back to reference Zeymer U, Schroder R, Machnig T, Neuhaus KL. Primary percutaneous transluminal coronary angioplasty accelerates early myocardial reperfusion compared to thrombolytic therapy in patients with acute myocardial infarction. Am Heart J. 2003;146:686–91.CrossRefPubMed Zeymer U, Schroder R, Machnig T, Neuhaus KL. Primary percutaneous transluminal coronary angioplasty accelerates early myocardial reperfusion compared to thrombolytic therapy in patients with acute myocardial infarction. Am Heart J. 2003;146:686–91.CrossRefPubMed
3.
go back to reference Valgimigli M, Saia F, Guastaroba P, et al., REAL Registry Investigators. Transradial versus transfemoral intervention for acute myocardial infarction: a propensity score-adjusted and –matched analysis from the REAL (REgistro regionale AngiopLastiche dell’Emilia-Romagna) multicenter registry. J Am Coll Cardiol Interv. 2012;5:23–35.CrossRef Valgimigli M, Saia F, Guastaroba P, et al., REAL Registry Investigators. Transradial versus transfemoral intervention for acute myocardial infarction: a propensity score-adjusted and –matched analysis from the REAL (REgistro regionale AngiopLastiche dell’Emilia-Romagna) multicenter registry. J Am Coll Cardiol Interv. 2012;5:23–35.CrossRef
4.
go back to reference Fefer P, Matetzky S, Gannot S, et al. Predictors and outcomes associated with radial versus femoral access for intervention in patients with acute coronary syndrome in a real-world setting: results from the Acute Coronary Syndrome Israeli Survey (ACSIS). J Invasive Cardiol. 2010;2014(26):398–402. Fefer P, Matetzky S, Gannot S, et al. Predictors and outcomes associated with radial versus femoral access for intervention in patients with acute coronary syndrome in a real-world setting: results from the Acute Coronary Syndrome Israeli Survey (ACSIS). J Invasive Cardiol. 2010;2014(26):398–402.
5.
go back to reference Mehran R, Pocock S, Nikolsky E, et al. Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials. JACC Cardiovasc Interv. 2011;4:654–64.CrossRefPubMed Mehran R, Pocock S, Nikolsky E, et al. Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials. JACC Cardiovasc Interv. 2011;4:654–64.CrossRefPubMed
6.
go back to reference Kinnaird TD, Stabile E, Mintz GS, et al. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol. 2003;92:930–5.CrossRefPubMed Kinnaird TD, Stabile E, Mintz GS, et al. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol. 2003;92:930–5.CrossRefPubMed
7.
go back to reference Rao SV, Jollis JG, Harrington RA, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA. 2004;292:1555–62.CrossRefPubMed Rao SV, Jollis JG, Harrington RA, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA. 2004;292:1555–62.CrossRefPubMed
8.
go back to reference Ndrepepa G, Berger PB, Mehilli J, et al. Periprocedural bleeding and 1‑year outcome after percutaneous coronary interventions: appropriate- ness of including bleeding as a component of a quadruple end point. J Am Coll Cardiol. 2008;51:690–7.CrossRefPubMed Ndrepepa G, Berger PB, Mehilli J, et al. Periprocedural bleeding and 1‑year outcome after percutaneous coronary interventions: appropriate- ness of including bleeding as a component of a quadruple end point. J Am Coll Cardiol. 2008;51:690–7.CrossRefPubMed
9.
go back to reference Pocock SJ, Mehran R, Clayton TC, et al. Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the acute catheterization and urgent intervention triage strategy trial. Circulation. 2010;121:43–51.CrossRefPubMed Pocock SJ, Mehran R, Clayton TC, et al. Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the acute catheterization and urgent intervention triage strategy trial. Circulation. 2010;121:43–51.CrossRefPubMed
10.
go back to reference Mehta SR, Jolly SS, Cairns J, et al., RIVAL Investigators. Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevation. J Am Coll Cardiol. 2012;60:2490–9.CrossRefPubMed Mehta SR, Jolly SS, Cairns J, et al., RIVAL Investigators. Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevation. J Am Coll Cardiol. 2012;60:2490–9.CrossRefPubMed
11.
go back to reference Zwaan EM, Koopman AG, Holtzer CA, et al. Revealing the impact of local access-site complications and upper extremity dysfunction post transradial percutaneous coronary procedures. Neth Heart J. 2015;23:514–24.CrossRefPubMedPubMedCentral Zwaan EM, Koopman AG, Holtzer CA, et al. Revealing the impact of local access-site complications and upper extremity dysfunction post transradial percutaneous coronary procedures. Neth Heart J. 2015;23:514–24.CrossRefPubMedPubMedCentral
12.
go back to reference Bertrand OF, Bélisle P, Joyal D, et al. Comparison of transradial and femoral approaches for percutaneous coronary interventions: a systematic review and hierarchical Bayesian meta-analysis. Am Heart J. 2012;163:632–48.CrossRefPubMed Bertrand OF, Bélisle P, Joyal D, et al. Comparison of transradial and femoral approaches for percutaneous coronary interventions: a systematic review and hierarchical Bayesian meta-analysis. Am Heart J. 2012;163:632–48.CrossRefPubMed
13.
go back to reference Hamm CW, Bassand JP, Agewall S, et al., ESC Committee for Practice Guidelines. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:2999–3054.CrossRefPubMed Hamm CW, Bassand JP, Agewall S, et al., ESC Committee for Practice Guidelines. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:2999–3054.CrossRefPubMed
14.
go back to reference Hermanides RS, Ottervanger JP, ten Berg JM, et al., On-TIME 2 Trial Investigators. Net clinical benefit of prehospital glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding: effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding score. J Invasive Cardiol. 2012;24:84–9.PubMed Hermanides RS, Ottervanger JP, ten Berg JM, et al., On-TIME 2 Trial Investigators. Net clinical benefit of prehospital glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding: effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding score. J Invasive Cardiol. 2012;24:84–9.PubMed
15.
go back to reference Austin PC. Some methods of propensity-score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations. Biom J. 2009;51:171–84.CrossRefPubMed Austin PC. Some methods of propensity-score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations. Biom J. 2009;51:171–84.CrossRefPubMed
16.
go back to reference Applegate RJ, Sacrinty MT, Kutcher MA, et al. Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007. Jacc Interv. 2008;1:317–26.CrossRef Applegate RJ, Sacrinty MT, Kutcher MA, et al. Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007. Jacc Interv. 2008;1:317–26.CrossRef
17.
go back to reference Verheugt FW, Steinhubl SR, Hamon M, et al. Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention. JACC Cardiovasc Interv. 2011;4:191–7.CrossRefPubMed Verheugt FW, Steinhubl SR, Hamon M, et al. Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention. JACC Cardiovasc Interv. 2011;4:191–7.CrossRefPubMed
18.
go back to reference Jolly SS, Yusuf S, Cairns J, et al., RIVAL trial group. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. 2011;377:1409–20.CrossRefPubMed Jolly SS, Yusuf S, Cairns J, et al., RIVAL trial group. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. 2011;377:1409–20.CrossRefPubMed
19.
go back to reference Romagnoli E, Biondi-Zoccai G, Sciahbasi A, et al. Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: The RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study. J Am Coll Cardiol. 2012;60:2481–9.CrossRefPubMed Romagnoli E, Biondi-Zoccai G, Sciahbasi A, et al. Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: The RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study. J Am Coll Cardiol. 2012;60:2481–9.CrossRefPubMed
20.
go back to reference Valgimigli M, Gagnor A, Calabró P, et al., MATRIX Investigators. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial. Lancet. 2015;385:2465–76.CrossRefPubMed Valgimigli M, Gagnor A, Calabró P, et al., MATRIX Investigators. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial. Lancet. 2015;385:2465–76.CrossRefPubMed
21.
go back to reference Jolly SS, Amlani S, Hamon M, Yusuf S, Mehta SR. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. Am Heart J. 2009;157:132–40.CrossRefPubMed Jolly SS, Amlani S, Hamon M, Yusuf S, Mehta SR. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. Am Heart J. 2009;157:132–40.CrossRefPubMed
22.
go back to reference Fetterly KA, Lennon RJ, Bell MR, Holmes DR Jr., Rihal CS. Clinical determinants of radiation dose in percutaneous coronary interventional procedures: influence of patient size, procedure complexity, and performing physician. JACC Cardiovasc Interv. 2011;4:336–43.CrossRefPubMed Fetterly KA, Lennon RJ, Bell MR, Holmes DR Jr., Rihal CS. Clinical determinants of radiation dose in percutaneous coronary interventional procedures: influence of patient size, procedure complexity, and performing physician. JACC Cardiovasc Interv. 2011;4:336–43.CrossRefPubMed
23.
go back to reference Benamer H, Louvard Y, Sanmartin M, et al. A multicentre comparison of transradial and transfemoral approaches for coronary angiography and PTCA in obese patients: the TROP registry. EuroIntervention. 2007;3:327–32.CrossRefPubMed Benamer H, Louvard Y, Sanmartin M, et al. A multicentre comparison of transradial and transfemoral approaches for coronary angiography and PTCA in obese patients: the TROP registry. EuroIntervention. 2007;3:327–32.CrossRefPubMed
24.
go back to reference Rao SV, Ou FS, Wang TY, et al. Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry. JACC Cardiovasc Interv. 2008;1:379–86.CrossRefPubMed Rao SV, Ou FS, Wang TY, et al. Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry. JACC Cardiovasc Interv. 2008;1:379–86.CrossRefPubMed
25.
go back to reference Ball WT, Sharieff W, Jolly SS, et al. Characterization of operator learning curve for transradial coronary interventions. Circ Cardiovasc Interv. 2011;4:336–41.CrossRefPubMed Ball WT, Sharieff W, Jolly SS, et al. Characterization of operator learning curve for transradial coronary interventions. Circ Cardiovasc Interv. 2011;4:336–41.CrossRefPubMed
26.
go back to reference Eccleshall SC, Banks M, Carroll R, Jaumdally R, Fraser D, Nolan J. Implementation of a diagnostic and interventional transradial programme: resource and organisational implications. Heart. 2003;89:561–2.CrossRefPubMedPubMedCentral Eccleshall SC, Banks M, Carroll R, Jaumdally R, Fraser D, Nolan J. Implementation of a diagnostic and interventional transradial programme: resource and organisational implications. Heart. 2003;89:561–2.CrossRefPubMedPubMedCentral
Metadata
Title
Effects of radial versus femoral artery access in patients with acute myocardial infarction: A large centre prospective registry
Authors
S. Kilic
R. S. Hermanides
J. P. Ottervanger
E. Kolkman
J. H. E. Dambrink
V. Roolvink
A. T. M. Gosselink
E. Kedhi
A. W. J. van ’t Hof
Zwolle Myocardial Infarction Study Group
Publication date
01-01-2017
Publisher
Bohn Stafleu van Loghum
Published in
Netherlands Heart Journal / Issue 1/2017
Print ISSN: 1568-5888
Electronic ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-016-0887-6

Other articles of this Issue 1/2017

Netherlands Heart Journal 1/2017 Go to the issue

Editor’s Comment

The new Editorial Board